Related Experiment Video

Updated: Mar 13, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K

Down-regulation of CYP27B1 gene expression in Iranian patients with relapsing-remitting multiple sclerosis

Zahra Rezaie1,1, Mohammad Taheri2,3,1, Leila Kohan1

  • 1Department of Biology, Arsanjan Branch, Islamic Azad University, Arsanjan, Iran.

Human Antibodies
|October 30, 2016
PubMed
Abstract

Insights

Vitamin D deficiency may contribute to multiple sclerosis (MS). This study found lower CYP27B1 enzyme expression in Relapsing-Remitting MS patients, particularly females, suggesting a link to disease risk.

Area of Science:

  • Neurology
  • Endocrinology
  • Genetics

Background:

  • Multiple sclerosis (MS) is a complex neurological disorder potentially linked to vitamin D deficiency.
  • The CYP27B1 gene encodes a key enzyme involved in vitamin D metabolism.

Purpose of the Study:

  • To compare CYP27B1 gene expression levels between Relapsing-Remitting MS (RRMS) patients and healthy individuals in Iran.
  • To investigate the association between CYP27B1 expression and MS risk factors.

Main Methods:

  • Quantitative RT-PCR was used to measure CYP27B1 gene expression.
  • RNA was extracted from blood samples of 50 RRMS patients and 50 healthy controls.
  • Expression levels were analyzed and compared between the groups.

Main Results:

  • CYP27B1 gene expression was significantly lower in RRMS patients compared to normal individuals (P=0.04).
  • Female RRMS patients exhibited a significant reduction in CYP27B1 expression compared to normal females (P=0.01).
  • No significant linear correlation was found between CYP27B1 expression and Expanded Disability Status Scale (EDSS) or disease duration.

Conclusions:

  • Reduced CYP27B1 expression in female MS patients may indicate increased vulnerability.
  • These findings highlight a potential role for vitamin D metabolism in MS pathogenesis, especially in women.
Keywords:
CYP27B1expressionmultiple sclerosisreal time PCR

More Related Videos

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform10:37

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Published on: November 30, 2016

8.7K
Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro16:13

Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro

Published on: June 13, 2011

20.5K

Related Concept Videos

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
87
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
631
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
61
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
692